Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Low Anterior Resection Syndrome
NCT05042700Phase 2Unknown
- Start
- Oct 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in low anterior resection syndrome (LARS). Status: unknown.
02
Drugs
melatonin
03
Conditions
low anterior resection syndrome (LARS)
Beyond the preview
Go deeper on NCT05042700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05042700.